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Introduction
C. albicans is a common opportunistic pathogen, often
part of the human microflora, causing minor infections,
such as mucosal candidiasis, in healthy individuals [17] but
also life-threatening infections in the immunocompromised
(HIV, cancer) and critically ill [16]. Although effective
antifungal treatments are available (poleynes, azoles,
echinocadins), there are increasing reports of resistance in
Candida species [5, 19] and an on-going need to develop
new antifungal agents. Plant polyphenolic compounds
extracted from tea leaves (Camellia sinensis) have been
shown to exhibit a variety of natural health benefits in
humans [9] and also to have antimicrobial properties.
Epicatechin (EP) and theaflavin (TF) derivatives have been
shown to have potentially useful antibacterial activity
against gram-positive and gram-negative bacteria [6, 20] as
well as yeasts and molds [14, 18]. Tea polyphenols have
also been shown to influence biofilm formation by C.
albicans [4]. Enhanced activity, when polyphenols are
tested either in combination or in the presence of other
antimicrobials, has also been observed, and they may even
suppress the emergence of resistance to existing antifungal
drugs [3, 13]. In earlier studies, we identified synergy when
EC and EF were combined in vitro against multidrug-
resistant gram-negative bacteria [1, 2]. 
In this study we assessed whether combinations of the
polyphenols epicatechin and theaflavin might be useful as
potential antifungal agents against isolates of the potential
pathogen, Candida albicans.
Materials and Methods
C. albicans NCTC 3255 and NCTC 3179 were purchased from
Pro-Lab Diagnostics, UK. ISO-sensitest broth and agar were
purchased from Oxoid, UK. Blank susceptibility discs were
purchased from Mast Group Ltd, UK. Samples of theaflavin (>95%
purity) were donated by Unilever, China, and epicatechin (>90%
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New antifungal agents are required to compensate for the increase in resistance to standard
antifungal agents of Candida albicans, which is an important opportunistic fungal pathogen
that causes minor infections in many individuals but very serious infections in those who are
immune-compromised. In this study, combinations of theaflavin and epicatechin are
investigated as potential antifungal agents and also to establish whether antifungal synergy
exists between these two readily accessible and cost-effective polyphenols isolated from black
and green tea. The results of disc diffusion assays showed stronger antibacterial activity of
theaflavin:epicatechin combinations against C. albicans NCTC 3255 and NCTC 3179, than that
of theaflavin alone. Minimum inhibitory concentrations (MICs) of 1,024 µg/ml with theaflavin and
128-256 µg/ml with theaflavin:epicatechin combinations were found. The fractional inhibitory
concentration indexes were calculated, and the synergy between theaflavin and epicatechin
against both isolates of C. albicans was confirmed. Theaflavin:epicatechin combinations show
real potential for future use as a treatment for infections caused by C. albicans.
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purity) was purchased from SigmaAldrich, UK. All media, agar,
and blank susceptibility discs were autoclaved prior to their use.
Broth Microtiter Dilution Assays
A 4.10 mg/ml TF stock solution was prepared by dissolving
81.92 mg of theaflavin in 0.50 ml of dimethylsulfoxide (DMSO)
before the addition of 19.50 ml of sterile ISO-sensitest broth. From
this stock solution, a double dilution was performed eight times
into ISO-sensitest broth to give solutions of TF with nine different
concentrations (4.1–0.016 mg/ml). A 2.05 mg/ml EC stock solution
was prepared by dissolving 40.96 mg of EC in 0.5 ml of DMSO
before the addition of 19.50 ml of sterile ISO-sensitive broth. From
this stock solution, a double dilution was performed five times
into ISO-sensitest broth to give solutions of EC with six different
concentrations (2.05–0.064 mg/ml). A fixed volume (50 µl) of TF
and EC was pipetted into each well of a microtiter plate, whereby
each row and column contained a fixed amount of one antimicrobial
agent and increasing concentrations of the other antimicrobial
agent, providing final well concentrations (including inoculum) of
4-1,024 µg/ml of TF and 16-512 µg/ml of EC. Control wells
contained either 2.5% DMSO alone, or TF alone (4-1,024 µg/ml).
Epicatechin alone (16-512 µg/ml) was also tested. A 100 µl volume
of a 5 × 103 colony forming unit (CFU)/ml suspension in ISO-
sensitest broth was pipetted in order to inoculate each well with
C. albicans NCTC 3255. This procedure was replicated for C. albicans
NCTC 3179. All microtiter plates were incubated at 37oC for 24 h.
A 3-fold replication of all experimental plates was undertaken,
allowing the results to be provided as mean values.
Each well was observed for turbidity at the end of the
incubation period. The lowest concentration at which no turbidity
could be observed was taken as the MIC. Fractional inhibitory
concentrations, indeces (FICIs) were determined based on the
method previously described [7], whereby the FICa = MIC of
compound a + compound b/MIC of compound a, the FICb = MIC
of compound b + compound a/MIC of compound b, and the FICIs
= FICa + FICb. Where a FICI value was calculated to be ≤0.5,
synergy was recorded. A value >0.5–4.0 was noted as an additive
effect and a value >4 was considered an antagonism effect between
theaflavin and epicatechin.
The MIC of epicatechin alone was also determined by mictotiter
dilution using wells containing 512-2,048 µg/ml for each of the C.
albicans isolates. All microtiter plates were performed in triplicate
and incubated at 37oC for 24 h. 
Disc Diffusion Assay
A TF stock solution was prepared by adding 0.50 g of theaflavin
powder to 5 ml of ethanol and stirring the resultant suspension
for 10 min to provide a 100 mg/ml solution. A 100 mg/ml stock
solution of epicatechin was prepared by gradually adding 0.05 g
of epicatechin powder to 5 ml of ethanol and stirring for 15-
20 min until the polyphenolic compound had dissolved. A combined
solution of theaflavin and epicatechin (2:1) was prepared by
adding 0.50 g of theaflavin and 0.25 g of epicatechin to 5 ml of
ethanol and stirring until both compounds had dissolved (15-
20 min).
Polyphenol-susceptibility discs were prepared by pipetting
10 ml volumes of the individual polyphenol solutions directly
onto blank discs. These were then dried for 20 min prior to the
addition of any further solutions, if required. Single and combined
discs (TF:EC) containing 2, 4, 6, and 8 mg of polyphenol were
made by pipetting the appropriate volume of stock solution directly
onto blank discs. Ethanol control discs were prepared using
identical volumes of ethanol. All discs were then allowed to dry in
a sterile Petri dish at room temperature, before their use, in order
to completely remove all traces of solvent and thus eliminate any
ethanol-mediated antifungal activity.
ISO-sensitive agar plates were independently inoculated with
5 × 103 CFU/ml solutions of C. albicans [15] using the standardization
method [12]. Plate 1 comprised discs containing 2, 4, 6, or 8 mg of
epicatechin and an ethanol control disc. Plate 2 comprised discs
with 2, 4, 6, or 8 mg of theaflavin and an ethanol control disc and
separate discs containing 2, 4, 6, or 8 mg of the 2:1 theaflavin:
epicatechin combination. All experimental plates were incubated
at 37oC for 24 h, after which the zones of inhibition were recorded
(mm). Six-fold replication of all experimental plates was performed
and the results were provided as mean values ± SE. Disc diffusion
assays were also repeated after stock solutions had been stored for
7 days at 4oC to assess whether the stability of the compounds
might affect the reproducibility of tests conducted using stored
discs.
Results and Discussion
Epicatechin alone had little activity aginst C. albicans
NCTC 3255 or NCTC 3179 (>2,048 µg/ml), but both strains
were inhibited by theaflavin (1,024 µg/ml) (Table 1). This
confirms previous findings that theaflavin alone has
antifungal activity but with much lower MIC values than
those previously reported [18]. Analysis of the results from
the tests using 2:1 combinations of theaflavin and epicatechin
revealed an even greater antifungal effect than that observed
using solutions containing theaflavin alone, with MICs of
Table 1. Minimum inhibitory concentration and fractional
inhibitory concentration indexes of theaflavin, epicatechin,
and theaflavin:epicatechin (2:1) combinations against isolates
of Candida albicans.
C. albicans
isolate number
Minimum inhibitory concentration (µg/ml)
TF EC TF + EC FICIs
NCTC 3255 1,024 (0) >2,048 (0) 256 (0) 0.313
NCTC 3179 1,024 (0) >2,048 (0) 128 (0) 0.188
MIC = minimum inhibitory concentration, FICIs = fractional inhibitory concentration
indexes, TF = theaflavin, EC = epicatechin.
Antifungal Synergy Between Theaflavin and Epicatechin 1324
September 2013⎪Vol. 23⎪No. 9
256 and 128 µg/ml for C. albicans isolates NCTC 3255 and
3179, respectively. The noticeable and significant increase
in antifungal activity suggests that synergy exists between
the two polyphenols, confirmed by the FICIs of <0.5 (Table 1).
In the disc diffusion assays, zones of inhibition ranged
from 10.2 mm (± 0.41) at 2 mg/disc to 14.5 mm (± 0.54) at
8 mg/disc against isolate NCTC 3255, and between 7.3 mm
(± 0.52) at 2 mg/disc and 12.6 mm (± 0.52) at 8 mg/disc
against isolate NCTC 3179. A significant difference in
activity was observed in assays using theaflavin and
epicatechin (2:1) in combination (Fig. 1). Combinations of
theaflavin and epicatechin (2:1) tested against C. albicans
isolate NCTC 3255 produced zones of inhibition ranging
between 13.6 mm (± 0.52) at 2 mg/disc and 22.8 mm
(± 0.75) at 8 mg/disc. Zones of inhibition produced by (2:1)
combinations of theaflavin:epicatechin against isolate NCTC
3179 range between 7.3 mm (± 0.42) at 2 mg/disc and
19.2 mm at 8 mg/disc.
Disc diffusion assays conducted with stock solutions
stored for 7 days at 4oC showed noticeable differences
compared with those performed with stock solutions used
immediately after preparation (Fig. 2). After 7 days, epicatechin
remained inactive against both strains of C. albicans, but the
antifungal action of theaflavin was also seen to be reduced.
Discs containing 8 mg of TF generated mean zones of
inhibition of 10.7 mm (± 0.41) and 10.1 mm (± 0.20) for
isolates NCTC 3255 and NCTC 3179, respectively, equivalent
to a 26% and 20% reduction in activity, respectively. This
could result from oxidation of the theaflavin, reducing
the amount of the biologically active polyphenol in the
formulation. Stored discs containing the theaflavin:epicatechin
(2:1) combinations also showed reduced antifungal activity
but to a much lesser extent, with a 7% and 7.1% reduction in
activity, respectively. The reason behind the lower reduction
in activity could be a protective effect of theaflavin by
epicatechin, with epicatechin acting as an antioxidant and
Fig. 1. Antifungal effects of theaflavin (TF), epicatechin (EC), and synergy between TF and EC against C. albicans NCTC 3255 (A)
and NCTC 3179 (B). 
Error bars are the standard error of the mean of three measurements. Zones include a 6 mm disc diameter.
Fig. 2. Antifungal effects of theaflavin (TF) and synergy between TF and epicatechin (EC) against C. albicans NCTC 3255 (A) and
NCTC 3179 (B) when used immediately and after storage at 4oC for 7 days. 
Mean results of three measurements. Zones include a 6 mm disc diameter.
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reducing the rate at which theaflavin is oxidized, thus
preserving a greater concentration of “active” theaflavin.
This interpretation would be compatible with the results
from a previous work, where the antioxidant ascorbic acid
was found to prolong the activity lifespan of the polyphenol
epigallocatechin gallate [8]. Further studies using HPLC
analysis should be undertaken to calculate optimum
storage times for theaflavin:epicatechin solutions. With the
addition of another antioxidant, such as ascorbic acid, the
shelf life of theaflavin and theaflavin:epicatechin combinations
might be further increased.
Although the mechanisms responsible for polyphenol
synergy are not fully understood, possible explanations
include protection of theaflavin by epicatechin, similar to
previous observations [8] in which ascorbic acid was shown
to enhance the antibacterial activity of epigallocatechin
gallate. Although the mechanism for the antimicrobial
activity of polyphenols is unknown, previous studies have
shown that theaflavins and catechins cause extensive
damage to the cell wall of C. albicans [18]. The addition of
epicatechin to theaflavin might intensify this pro-oxidant
effect by further weakening the cell wall prior to any
interaction with theaflavin, thereby reducing the concentration
of theaflavin required for antifungal activity.
In conclusion, the results of this preliminary study
highlight the synergy between theaflavin and epicatechin,
when used against C. albicans, which could be harnessed to
improve their antifungal activity. Any potential use of
theaflavin:epicatechin combinations as a systemic treatment
will need further investigation, given the relatively high
MICs observed in vitro and the poor bioavailability of
polyphenols [11]. However, a topical preparation could be
useful as a treatment for skin or mucosal C. albicans infections,
capitalizing on both the antifungal and antioxidant properties
[10], which may be advantageous in promoting wound
healing. Future research should look into the mechanisms
behind the intrinsic, synergistic antimicrobial and antioxidant
properties of these natural compounds
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